Brivaracetam 00121-1075-02
Generic: Brivaracetam Injection
- Manufacturer
- Pai Holdings, Llc Dba Pai Pharma
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- February 23, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA218249
Active Ingredients
| Ingredient | Strength |
|---|---|
| Brivaracetam | 50 mg/5mL |
Drug Class
Epoxide Hydrolase Inhibitors [MoA]
Selected Package
00121-1075-02Selected10 VIAL, GLASS in 1 CARTON (0121-1075-02) / 5 mL in 1 VIAL, GLASS (0121-1075-55)